Search Results - "Kazanov, Diana"
-
1
Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers
Published in PloS one (08-06-2016)“…Terpinen-4-ol, a naturally occurring monoterpene is the main bioactive component of tea-tree oil and has been shown to have many biological activities. To…”
Get full text
Journal Article -
2
Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells
Published in Clinical cancer research (15-09-2005)“…Purpose: Multiple studies have indicated that cyclooxygenase-2 (COX-2) inhibitors may prevent colon cancer, which is one of the leading causes of cancer death…”
Get full text
Journal Article -
3
CD24 Is a New Oncogene, Early at the Multistep Process of Colorectal Cancer Carcinogenesis
Published in Gastroenterology (New York, N.Y. 1943) (01-08-2006)“…Background & Aims: The aim of this study was to identify genes that play a role in colorectal cancer (CRC) carcinogenesis by analysis of differential gene…”
Get full text
Journal Article -
4
Celecoxib leads to G2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner
Published in European journal of cancer (1990) (01-02-2006)“…A unique in vitro system has been developed in our lab that consists of normal enterocytes derived from the rat ileum (IEC-18 cells) and their transformed…”
Get full text
Journal Article -
5
Targeting the active β-catenin pathway to treat cancer cells
Published in Molecular cancer therapeutics (01-11-2006)“…The adenomatous polyposis coli or β-catenin genes are frequently mutated in colorectal cancer cells, resulting in oncogenic activation of β-catenin signaling…”
Get full text
Journal Article -
6
Gene Expression Analysis Proposes Alternative Pathways for the Mechanism by Which Celecoxib Selectively Inhibits the Growth of Transformed but not Normal Enterocytes
Published in Clinical cancer research (15-11-2007)“…Purpose: Cyclooxygenase-2 inhibitor (celecoxib, Pfizer) is a promising chemopreventive agent, yet its long-term use may be limited due to increased…”
Get full text
Journal Article -
7
Celecoxib But Not Rofecoxib Inhibits the Growth of Transformed Cells in Vitro
Published in Clinical cancer research (01-01-2004)“…Purpose: Nonsteroidal anti-inflammatory drugs reduce the risk of colorectal cancer. The cyclooxygenase (COX) pathway of arachidonic acid metabolism is an…”
Get full text
Journal Article -
8
The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews
Published in European journal of cancer (1990) (01-11-2013)“…The p.I1307K adenomatous polyposis coli (APC) gene variant, prevalent among Ashkenazi Jews, may increase the risk for colorectal neoplasia. We studied the…”
Get full text
Journal Article -
9
Selective eradication of cancer cells by delivery of adenovirus-based toxins
Published in Oncotarget (13-06-2017)“…KRAS mutation is an early event in colorectal cancer carcinogenesis. We previously reported that a recombinant adenovirus, carrying a pro-apoptotic gene (PUMA)…”
Get full text
Journal Article -
10
-
11
-
12
-
13
-
14
APC I1307K polymorphism as a predictive factor for colorectal neoplasia recurrence
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 1526 Background: The use of surveillance colonoscopy to detect disease recurrence after initial colorectal neoplasia resection has increased…”
Get full text
Journal Article -
15
CD24 is an Important Oncogene in the Colon
Published in Gastroenterology (New York, N.Y. 1943) (2011)Get full text
Journal Article -
16
-
17
The APC p. I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews
Published in European journal of cancer (1990) (2013)“…Abstract Background The p.I1307K adenomatous polyposis coli ( APC ) gene variant, prevalent among Ashkenazi Jews, may increase the risk for colorectal…”
Get full text
Journal Article -
18
Mo1969 The APC I1307k Polymorphism Is a Significant Risk Factor for CRC in Average Risk Ashkenazi Jews
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)Get full text
Journal Article -
19
Tu1909 APC I1307k Is a Predictive Factor for Adenoma Recurrence
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)Get full text
Journal Article -
20
Tu1940 CD24 Polymorphisms and Susceptibility to Inflammatory Bowel Disease
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2014)Get full text
Journal Article